Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
PR Newswire —
SHANGHAI and BOSTON, Jan. 11, 2026 /PRNewswire/ -- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, today announced that Dr. Dongxu Shu, Co-Founder, Chairman of the Board, and Chief Executive...